Mark Frasier
- Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments 23
- Neurological disorders and treatments 13
- Botulinum Toxin and Related Neurological Disorders 3
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments 23
- Neurological disorders and treatments 13
- Botulinum Toxin and Related Neurological Disorders 3
-
- Nuclear Receptors and Signaling 2
- Physiology top 5%
- Alzheimer's disease research and treatments 5
-
- Autism Spectrum Disorder Research 4
-
- RNA regulation and disease 2
-
- Restless Legs Syndrome Research 2
- Co-authors
- Benjamin WolozinKuldip D. DavePeter S. ChoiHeather M. SnyderCatherine TheislerWassilios G. MeissnerDavid M. WeinerChristopher G. Goetz
- Journals
- Movement Disorders (5 papers)Experimental Neurology (3 papers)Journal of Parkinson s Disease (2 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Mark Frasier
27 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Neurology 1.0k
- Neurology 264
- Cellular and Molecular Neuroscience 449
- Physiology 448
- Biological Psychiatry 19
Countries citing papers authored by Mark Frasier
This map shows the geographic impact of Mark Frasier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Frasier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Frasier more than expected).
Fields of papers citing papers by Mark Frasier
This network shows the impact of papers produced by Mark Frasier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Frasier. The network helps show where Mark Frasier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Frasier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 13 | |
| 2 | 2022 | 6 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 52 | |
| 5 | 2019 | 14 | |
| 6 | 2017 | 117 | |
| 7 | 2017 | 51 | |
| 8 | 2017 | 69 | |
| 9 | 2016 | 5 | |
| 10 | 2013 | 67 | |
| 11 | 2013 | 137 | |
| 12 | 2013 | 5 | |
| 13 | 2011 | 342 | |
| 14 | 2010 | 13 | |
| 15 | 2009 | 4 | |
| 16 | 2005 | 131 | |
| 17 | 2005 | 16 | |
| 18 | 2004 | 11 | |
| 19 | 2004 | 91 | |
| 20 | 2002 | 180 |
About Mark Frasier
Mark Frasier is a scholar working on Neurology, Behavioral Neuroscience, Complementary and alternative medicine, Neurology and Physiology, having authored 28 papers that have together received 1.5k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (23 papers), Neurological disorders and treatments (13 papers), Alzheimer's disease research and treatments (5 papers), Autism Spectrum Disorder Research (4 papers), Botulinum Toxin and Related Neurological Disorders (3 papers), RNA regulation and disease (2 papers), Restless Legs Syndrome Research (2 papers) and Nuclear Receptors and Signaling (2 papers). The work is most often cited by research in Neurology (1.0k citations), Neurology (264 citations), Cellular and Molecular Neuroscience (449 citations), Physiology (448 citations) and Biological Psychiatry (19 citations). Mark Frasier has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Benjamin Wolozin, Kuldip D. Dave, Peter S. Choi, Heather M. Snyder, Catherine Theisler, Wassilios G. Meissner, David M. Weiner, Christopher G. Goetz, François Tison and Erwan Bézard. Their work appears in journals such as Movement Disorders, Experimental Neurology, Journal of Parkinson s Disease, Disease Models & Mechanisms and Frontiers in Aging Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.